{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1361981471451553408.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1093/ndt/15.7.1014"}},{"identifier":{"@type":"URI","@value":"http://academic.oup.com/ndt/article-pdf/15/7/1014/23368080/151014.pdf"}},{"identifier":{"@type":"NAID","@value":"30018451308"}}],"dc:title":[{"@value":"Arterial stiffening and vascular calcifications in end‐stage renal disease"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1381981471451553408","@type":"Researcher","foaf:name":[{"@value":"Alain P. Guérin"}]},{"@id":"https://cir.nii.ac.jp/crid/1381981471451553409","@type":"Researcher","foaf:name":[{"@value":"Gérard M. London"}]},{"@id":"https://cir.nii.ac.jp/crid/1381981471451553410","@type":"Researcher","foaf:name":[{"@value":"Sylvain J. Marchais"}]},{"@id":"https://cir.nii.ac.jp/crid/1381981471451553411","@type":"Researcher","foaf:name":[{"@value":"Fabien Metivier"}]}],"publication":{"publicationIdentifier":[{"@type":"EISSN","@value":"14602385"},{"@type":"PISSN","@value":"09310509"},{"@type":"PISSN","@value":"http://id.crossref.org/issn/09310509"},{"@type":"PISSN","@value":"https://id.crossref.org/issn/09310509"}],"prism:publicationName":[{"@value":"Nephrology Dialysis Transplantation"}],"dc:publisher":[{"@value":"Oxford University Press (OUP)"}],"prism:publicationDate":"2000-07-01","prism:volume":"15","prism:number":"7","prism:startingPage":"1014","prism:endingPage":"1021"},"reviewed":"false","url":[{"@id":"http://academic.oup.com/ndt/article-pdf/15/7/1014/23368080/151014.pdf"}],"createdAt":"2002-07-26","modifiedAt":"2021-05-17","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360025431098177664","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Serum calciprotein particle‐to‐phosphate ratio as a predictor of cardiovascular events in incident hemodialysis patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567184852694784","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Prognostic value of pre-dialysis blood pressure and risk threshold on clinical outcomes in hemodialysis patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1360846643059005952","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Clinical Practice Guideline for the Management of Chronic Kidney Disease‐Mineral and Bone Disorder"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204431821312","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Levels of Serum Phosphorus and Cardiovascular Surrogate Markers"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204433333120","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Serum Fibroblast Growth Factor-23 Levels and Progression of Aortic Arch Calcification in Non-Diabetic Patients on Chronic Hemodialysis"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204433517312","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Arterial Stiffness in Patients with Non-Diabetic Chronic Kidney Disease (CKD)"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204674468224","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Dramatic reduction of the tumoral calcification treated with sevelamer hydrochloride and surgical removal of autotransplanted parathyroid tissue"},{"@value":"Ｓｅｖｅｌａｍｅｒ　ｈｙｄｒｏｃｈｌｏｒｉｄｅの投与と前腕副甲状腺移植片の外科的摘出により劇的に縮小した腫瘤状石灰化の１例"},{"@language":"ja-Kana","@value":"ショウレイ ホウコク Sevelamer hydrochloride ノ トウヨ ト ゼンワン フクコウジョウセン イショクヘン ノ ゲカテキ テキシュツ ニ ヨリ ゲキテキ ニ シュクショウ シタ シュリュウジョウ セッカイカ ノ 1レイ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204675398784","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@value":"５．塩酸セベラマーの臨床　　第４９回日本透析医学会シンポジウムより"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204676258816","@type":"Article","relationType":["isReferencedBy","isCitedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"透析患者の循環器合併症Ｕｐ　ｔｏ　Ｄａｔｅ"},{"@value":"透析患者の循環器合併症 Up to Date--第51回日本透析医学会教育講演より"},{"@language":"ja-Kana","@value":"トウセキ カンジャ ノ ジュンカンキ ガッペイショウ Up to Date ダイ 51カイ ニホン トウセキ イガクカイ キョウイク コウエン ヨリ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204676824320","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"The factors affecting aortic and valvular calcification in hemodialysis patients"},{"@value":"血液透析患者の大動脈ならびに心臓弁の石灰化に影響を与える因子の検討"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204680492544","@type":"Article","relationType":["isReferencedBy","isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Serum levels of advanced glycation end-products in hemodialysis patients  -Effect of sevelamer hydrochloride-"},{"@language":"ja","@value":"透析患者における血清終末糖化産物（ＡＧＥｓ）濃度　　‐セベラマー塩酸塩投与の効果‐"},{"@value":"透析患者における血清終末糖化産物(AGEs)濃度--セベラマー塩酸塩投与の効果"},{"@language":"ja-Kana","@value":"トウセキ カンジャ ニ オケル ケッセイ シュウマツ トウカ サンブツ AGEs ノウド セベラマー エンサンエン トウヨ ノ コウカ"},{"@value":"Serum levels of advanced glycation end-products in hemodialysis patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204720911360","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy","isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Left Ventricular Hypertrophy Is Associated with Arterial Stiffness and Vascular Calcification in Hemodialysis Patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204870647808","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Screening of Vascular Calcification in Hemodialysis Patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205103260672","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Aortic Arch Calcification and Arterial Stiffness are Independent Factors for Diastolic Left Ventricular Dysfunction in Chronic Hemodialysis Patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679218986112","@type":"Article","relationType":["isReferencedBy","isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Aortic Arch Calcification and Clinical Outcome in Patients with End-Stage Renal Disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679220048384","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Risk Factors Associated with Coronary Artery Calcification Should Be Examined before Kidney Transplantation"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679220772736","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Utilization of titanium oxide-like compound as an inorganic phosphate adsorbent for the control of serum phosphate level in chronic renal failure"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679251955072","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"新規高リン血症治療剤スクロオキシ水酸化鉄（ピートル<sup>®</sup>チュアブル錠250 mg，500 mg）の薬理学的特性，製剤学的特性および臨床試験成績"},{"@language":"en","@value":"Pharmacological, pharmaceutical and clinical profiles of sucroferric oxyhydroxide (P-TOL<sup>®</sup> Chewable Tab. 250 mg, 500 mg), a therapeutic agent for hyperphosphatemia"},{"@value":"新薬紹介総説 新規高リン血症治療剤スクロオキシ水酸化鉄(ピートルチュアブル錠250mg, 500mg)の薬理学的特性,製剤学的特性および臨床試験成績"},{"@language":"ja-Kana","@value":"シンヤク ショウカイ ソウセツ シンキ コウリン ケッショウ チリョウザイ スクロオキシ スイサンカテツ(ピートルチュアブルジョウ 250mg, 500mg)ノ ヤクリガクテキ トクセイ,セイザイガクテキ トクセイ オヨビ リンショウ シケン セイセキ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679656936192","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Clinical Practice Guideline for CKD-MBD"},{"@language":"ja","@value":"慢性腎臓病に伴う骨・ミネラル代謝異常の診療ガイドライン"},{"@value":"社団法人 日本透析医学会 慢性腎臓病に伴う骨・ミネラル代謝異常の診療ガイドライン"},{"@language":"ja-Kana","@value":"シャダン ホウジン ニホン トウセキ イガッカイ マンセイ ジンゾウビョウ ニ トモナウ ホネ ・ ミネラル タイシャ イジョウ ノ シンリョウ ガイドライン"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679656988032","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Serum levels of advanced glycation end-products (AGEs) in dialysis patients"},{"@language":"ja","@value":"透析患者における血清終末糖化産物（AGEs）濃度"},{"@value":"透析患者における血清終末糖化産物(AGEs)濃度 : セベラマー塩酸塩少量投与の効果"},{"@language":"ja-Kana","@value":"トウセキ カンジャ ニ オケル ケッセイ シュウマツ トウカ サンブツ(AGEs)ノウド : セベラマー エンサンエン ショウリョウ トウヨ ノ コウカ"},{"@value":"Serum levels of advanced glycation end-products (AGEs) in dialysis patients -Effects of low-dose sevelamer hydrochloride-"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679657467776","@type":"Article","relationType":["isReferencedBy","isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"The effects of sevelamer hydrochloride on metabolic acidosis in hemodialysis patients with citrate dialysate"},{"@language":"ja","@value":"塩酸セベラマー内服量が血液透析患者の酸塩基平衡に及ぼす影響―クエン酸透析液使用でも，代謝性アシドーシスを悪化させるか？―"},{"@language":"ja-Kana","@value":"エンサン セベラマー ナイフクリョウ ガ ケツエキ トウセキ カンジャ ノ サンエンキ ヘイコウ ニ オヨボス エイキョウ クエンサン トウセキエキ シヨウ デモ タイシャセイ アシドーシス オ アッカ サセル カ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679695468160","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy","isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Usefulness of Brachial-Ankle Pulse Wave Velocity Measurement: Correlation with Abdominal Aortic Calcification."}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679696949760","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy","isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"<B>Assessment of Coronary Artery Calcification in Hemodialysis Patients Using Multi-Detector Spiral CT Scan</B>"},{"@value":"Assessment of Coronary Artery Calcification in Hemodialysis Patients Using Multi-Detector Spiral CT Scan"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679752520960","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Phosphate Binding Capacities of Therapeutic Agents for Hyperphosphatemia"},{"@language":"ja","@value":"種々高リン血症治療薬のリン酸吸着能に関する基礎的検討"}]},{"@id":"https://cir.nii.ac.jp/crid/1390291932685205888","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Reduction in Arterial Stiffness after Switching from Pravastatin or Atorvastatin to Fluvastatin"}]},{"@id":"https://cir.nii.ac.jp/crid/1520290882289009792","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@value":"CKD患者の脈波速度上昇に対する骨ミネラル代謝異常(MBD)の関与の検討"},{"@language":"ja-Kana","@value":"CKD カンジャ ノ ミャクハ ソクド ジョウショウ ニ タイスル コツ ミネラル タイシャ イジョウ MBD ノ カンヨ ノ ケントウ"}]},{"@id":"https://cir.nii.ac.jp/crid/1571135649439156864","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Renal osteodystrophy: present and future"}]},{"@id":"https://cir.nii.ac.jp/crid/1571135651190668288","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Clinical assessment of atherosclerotic parameters and cardiac function in chronic hemodialysis patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1571980075183504000","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Higher Brachial-Ankle Pulse Wave Velocity Is Associated with More Advanced Carotid Atherosclerosis in End-Stage Renal Disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1573950400264475008","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Determinants of Arterial Wall Stiffness and Peripheral Artery Occlusive Disease in Nondiabetic Hemodialysis Patients"}]},{"@id":"https://cir.nii.ac.jp/crid/2050025942144287232","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Impact of non-invasive cardiovascular screening programs as a predictor of cardiovascular events among asymptomatic chronic kidney disease patients"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1093/ndt/15.7.1014"},{"@type":"CIA","@value":"30018451308"},{"@type":"CROSSREF","@value":"10.1097/md.0000000000013485_references_DOI_2decbFHCJVGXNTCzhuLiSP7uRFI"},{"@type":"CROSSREF","@value":"10.1620/tjem.226.137_references_DOI_2decbFHCJVGXNTCzhuLiSP7uRFI"},{"@type":"CROSSREF","@value":"10.2152/jmi.57.275_references_DOI_2decbFHCJVGXNTCzhuLiSP7uRFI"},{"@type":"CROSSREF","@value":"10.2169/internalmedicine.49.4514_references_DOI_2decbFHCJVGXNTCzhuLiSP7uRFI"},{"@type":"CROSSREF","@value":"10.5551/jat.e602_references_DOI_2decbFHCJVGXNTCzhuLiSP7uRFI"},{"@type":"CROSSREF","@value":"10.5649/jjphcs.37.63_references_DOI_2decbFHCJVGXNTCzhuLiSP7uRFI"},{"@type":"CROSSREF","@value":"10.30548/vascfail.5.1_23_references_DOI_2decbFHCJVGXNTCzhuLiSP7uRFI"},{"@type":"CROSSREF","@value":"10.1111/1744-9987.14203_references_DOI_2decbFHCJVGXNTCzhuLiSP7uRFI"},{"@type":"CROSSREF","@value":"10.1253/circj.cj-08-0308_references_DOI_2decbFHCJVGXNTCzhuLiSP7uRFI"},{"@type":"CROSSREF","@value":"10.4009/jsdt.43.373_references_DOI_2decbFHCJVGXNTCzhuLiSP7uRFI"},{"@type":"CROSSREF","@value":"10.5551/jat.5595_references_DOI_2decbFHCJVGXNTCzhuLiSP7uRFI"},{"@type":"CROSSREF","@value":"10.4009/jsdt.44.1015_references_DOI_2decbFHCJVGXNTCzhuLiSP7uRFI"},{"@type":"CROSSREF","@value":"10.4009/jsdt.45.301_references_DOI_2decbFHCJVGXNTCzhuLiSP7uRFI"},{"@type":"CROSSREF","@value":"10.1007/s10157-015-1169-0_references_DOI_2decbFHCJVGXNTCzhuLiSP7uRFI"},{"@type":"CROSSREF","@value":"10.1620/tjem.223.79_references_DOI_2decbFHCJVGXNTCzhuLiSP7uRFI"},{"@type":"CROSSREF","@value":"10.4009/jsdt.40.215_references_DOI_2decbFHCJVGXNTCzhuLiSP7uRFI"},{"@type":"CROSSREF","@value":"10.1111/1744-9987.12058_references_DOI_2decbFHCJVGXNTCzhuLiSP7uRFI"},{"@type":"CROSSREF","@value":"10.4009/jsdt.46.467_references_DOI_2decbFHCJVGXNTCzhuLiSP7uRFI"},{"@type":"CROSSREF","@value":"10.1291/hypres.27.527_references_DOI_2decbFHCJVGXNTCzhuLiSP7uRFI"},{"@type":"CROSSREF","@value":"10.1291/hypres.26.163_references_DOI_2decbFHCJVGXNTCzhuLiSP7uRFI"},{"@type":"CROSSREF","@value":"10.5551/jat.31153_references_DOI_2decbFHCJVGXNTCzhuLiSP7uRFI"},{"@type":"CROSSREF","@value":"10.1291/hypres.27.47_references_DOI_2decbFHCJVGXNTCzhuLiSP7uRFI"},{"@type":"CROSSREF","@value":"10.1254/fpj.151.75_references_DOI_2decbFHCJVGXNTCzhuLiSP7uRFI"}]}